Table 1 Characteristics of the 11 patients with COVID-19
N = 11 | Total |
|---|---|
Age, mean (SD), years | 61 (12) |
Male sex, No. (%) | 9 (82) |
Body weight, mean (SD), kg | 71 (23) |
Diabetes mellitus, No. (%) | 5 (45) |
Hypertension, No. (%) | 7 (63) |
Sleep apnea syndrome, No. (%) | 2 (18) |
PaO2/FIO2 ratio at intubation, mean (SD) | 210 (82) |
PEEP at intubation, mean (SD), cmH2O | 10 [10, 12] |
LDH on admission, median [IQR], IU/L | 504 [387, 582] |
CRP on admission, median [IQR], mg/dL | 12.7 [4.8, 19.1] |
PCT on admission, median [IQR], ng/mL | 0.19 [0.1, 0.36] |
Time from first symptom appearance, mean (SD), days | |
At intubation | 10.3 (2.9) |
At discharge | 21.5 (2.9) |
1 month after | 55.5 (9.8) |
Time from first symptom appearance, mean (SD), days | |
Favipiravir | 9.0 (2.3) |
Heparin | 11.5 (3.4) |
Steroid | 13.7 (2.7) |
Intubation | 10.6 (2.8) |
Symptoms at 1 month, No (%) | |
Muscle weakness | 8 (73) |
Fatigability | 6 (55) |
Body pain | 3 (27) |
Dyspnea | 2 (18) |
Cough | 0 (0) |
Ventilator days, median [IQR], days | 10.1 (2.2) |